Imidomics

Imidomics

Focuses on developing new medicines for immune-mediated inflammatory diseases. Learn more

Launch date
Employees
Market cap
-
Enterprise valuation
€60—90m (Dealroom.co estimates Jul 2021.)
San Francisco California (HQ)
Authorizing premium user...